Tevogen Inc. TVGN
7.25
(0.60)
(7.64%)
as of 25 Sep
- Market cap
- $51.1M
- P/E
- 0.0×
Follow TVGN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
0.31 | 0.22 | 0.29 | 0.33 |
Net Debt/EBITDA |
(0.59) | (0.85) | (1.07) | (0.95) | |
Debt/Assets |
97.91% | 100.39% | 130.05% | 135.37% | |
Debt/Equity |
(0.56) | (0.53) | (0.65) | (0.72) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.64 | 0.44 | 0.49 | 0.51 | |
Capex/Depreciation |
0.00 | (0.75) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.93) | (0.68) | (0.78) | (0.78) | |
Cash per Share |
0.26 | 0.17 | 0.20 | 0.28 | |
Shareholders Equity per Share |
(2.00) | (2.48) | (2.82) | (2.32) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.00) | (2.48) | (2.82) | (2.32) | |
Free Cash Flow |
(3.65) | (2.25) | (2.73) | (3.01) | |
Working Capital |
(4.62) | (5.53) | (5.13) | (4.14) | |
Capital Expenditures |
— | (0.06) | — | — | |
Net Current Asset Value |
(10.20) | (11.08) | (12.62) | (11.61) | |
| Other line items | |||||
Quick Ratio |
0.18 | 0.10 | 0.12 | 0.20 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.93) | (0.66) | (0.78) | (0.78) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Average Receivables |
0.16 | 0.16 | 0.16 | 0.16 | |
Average Payables |
4.58 | 4.27 | 4.23 | 3.53 | |
Average Assets |
4.39 | 3.92 | 4.50 | 4.50 | |
Average Common Equity |
(14.81) | (16.25) | (17.58) | (17.99) | |
Capex to Sales |
— | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates